N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L-proline
CAS:565453-40-9
Formula:
C17H26N2O4
Purity:
97%
Color and Shape:
Solid
Molecular weight:
322.3993
Ref: IN-DA0038MT
100mg | 270.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Vildagliptin Impurity 3 Trifluoroacetate (Carboxy Acid Metabolite)
Formula:
C17H26N2O4·C2HF3O2
Color and Shape:
White To Off-White Solid
Molecular weight:
322.41 114.02
Ref: 4Z-V-221
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L-proline
CAS:565453-40-9
Purity:
97%
Molecular weight:
322.4049987792969
Ref: 10-F862471
100mg | 267.00 € | ||
250mg | 629.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
Vildagliptin Carboxylic Acid Lithium Salt Hydrate
Controlled ProductCAS:565453-40-9
Applications The major metabolite of Vildagliptin (V305000). References Reimer, M.K., et al.: Eur. J. Endocrinol., …
Formula:
C17H25LiN2O4
Color and Shape:
Neat
Molecular weight:
328.33
Ref: TR-V305015
5mg | 244.00 € | ||
50mg | 1,632.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L-proline
Controlled ProductCAS:565453-40-9
Applications N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L-proline, is a metabolite of Vildagliptin (V305000), a class of oral anti-hyperglycemic agents that …
Formula:
C17H26N2O4
Color and Shape:
Neat
Molecular weight:
322.399
Ref: TR-H296965
25mg | 283.00 € | ||
100mg | 1,021.00 € | ||
250mg | 1,887.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Vildagliptin Carboxylic Acid Lithium Salt Hydrate
CAS:565453-40-9
Please enquire for more information about Vildagliptin Carboxylic Acid Lithium Salt Hydrate including the price, …
Formula:
C17H25LiN2O4·xH2O
Purity:
Min. 95%
Molecular weight:
328.33 g/mol
Ref: 3D-QXA45340
50mg | To inquire | ||
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025